Saturated metabolites op progesterone in human myometrium during pregnancy

Saturated metabolites op progesterone in human myometrium during pregnancy

65 SATURATED METABOLITES IN HUMAN OF PROGESTERONE MYOMETRIUM DURING PREGNANCY by Hiakan H, I. Frauenklinik Univereitlt und Hebammenschule ...

782KB Sizes 1 Downloads 97 Views

65 SATURATED

METABOLITES

IN HUMAN

OF PROGESTERONE

MYOMETRIUM

DURING

PREGNANCY

by Hiakan

H,

I. Frauenklinik Univereitlt

und

Hebammenschule

Munchen,

D - 8 Winchen

11,

Maiatral3e

Germany

Received: 10/l/75 SUMMARY A method for the aeparation and quantitative determination of epimoria 3q/D-hydroxy-54/&pregnan-2O-onea bygaa liquid chromatography and elootron capture detection ia preaented. Reliability of the method and applicability to biological material waa teated.In one total human uterus and 20 aamplea of myometrium the concentration of epimeria pregnanolonee waa determined. 3D-hydroxy-Sa-pregnan-20-one and 3a-hydroxy-5ty-pregnan-20-one were preaent in similar quantitative range aa progesterone and 20a-hydroxy-&pregen3-one.A correlation between progesterone and concentration of metabolitea could not be eatabliahed. 3B-hydrory-5I3pregnan-20-one wae not deteated in the tissue.

INTRODUCTION In vitro muaale

from

ltudiea

rat

ia metabolized and

alao

POa-OH-P

in human (5)

myometrium

there

Therefore the amount

lee of human

Vo'owne27, Nmber

uterine

Z

during

from

(PO&-OH-P)

on progesterone pregnancy

ia no information

of metabolitea

in uterine

(4) progesterone

to 20Whydroxy-4-pregnen-y-one

of the report

tiaaue.

that

(3) and human

lxaeption

& Zander

determine

(1,2),aheep

producta.

centration thie

demonstrated

Sa-aaturated

With

baum

have

endogenoua

a aeneitive of 5a-saturated

method

and

by Runne-

about

the con-

progesterone waa

devised

metabolitee

in to

in camp-

muscle.

m

WBaOXDI

January,

1976

66

S

YJ?=EIEOXD6

Solvent% were redistilled before use. Reference steroids were obtained from commercial sources and recryF stallized. Thin layer chromatonraphv (TLC) was performed on 20 x 20 cm glas% plates coated with silica gel GF 254 (Merck AG) at 0.25 mm thiokneas. After drying at roomtemperature the plates were activated at 110 C and stored in a desiccator until used. Steroids were located by spraying with anisaldehyde-sulfuric acid and heating at 100 C for 10 min. Radioactive labelled material was detected using a thin layer scanner (Berthold & Frieseke, Mod. LB 2723). Gas liauid chromatography (GLC): A Packard GLC appa(Series 7400) equipped with two flame ionisation deID ) or two electron capture detectors (ECD) was foil was the electron emitting source in the ECDs. Gla%s columns of 3 ft. and 6 ft. length and 4 or 2.5 mm internal diameter were prepared azdpacked as described (6) with Gas Chrom Q (100 - 120 me%h, Serva AG, Heidelberg). The following istationary phases were used: QF-1 (15 and 3$)! XE-60 (2% and 3%)~ OV-225 (396). Nitrogen purified by microsieve filter% was used as carrier gas. Columns were maintained at 240°C and detector% at 270°C. Testosterone or testosterone monochloracetate was used as internal standard during GLC. ratus

Trimethylsilyl (TMSI)-ethers were preDerivatives: ust prior to GLC as de%crZbed (7). The reagent was N-methyl-N-trimethylsilyl-tri~oroacetamida,M~cherey & Nagel Comp., Dtiren). Steroid monochloroacetates (ClAc) were formed a% described (8) Hexadecafluoronanoyl derivatives (HFN) were prepared according to the procedure of Kirschner and Taylor (9). Sulfate derivative% of steroid% were prepared as described previously (10). All derivative% with exception of TMSI-ethers were recrystaLlized before u%e. Tissue aamplesr Two specimens of myometrium of the pbstovulatory &a:;do4f2~;Ycle, 18 specimen* from 9 uteri between the 11 week of pregnancy and one total uterus were obtained at hysterectomy or interruption of pregnancy for medical reason%. The tissue was blotted, minced an homogenized with an Ultra-Turrax after adding two volume% of digtilled water. Extraction: After adgition of (3H)-3D-hydroxy-s-pregnan-20-one (3G-%P) and ( H)-k-sulfoxy-5D-pregnan-20-one of both 50.3 Ci/mmole, (3%+5B-Pso~),( specific activity New Englan Nuclear),the homogenates were extracted 4 times with 20 ml of diethylether-ethanol (1:3, vfv).The extracts were evaporated in vacua and the residue dissolved

S

67

lC3EOXDll

in 10 ml of 70% methanol which was stored at -2OoC overlipid material was sedimented and night. By centrifugation the supernatant extracted with 3 x 10 ml diethylether resulting in the "free" fraction.The aqueous phase containing the "sulfate" fraction was extracted with 3 x 10 ml n-butanol. Chromatoarauhvt The butanol extract was evaporated and chromatographed on a 1 x 15 cm Sephadex-LH-PC column in system chloroform-methanol lrl, containing 0.1 mM NaCl (11). The purified "sulfate" fraction obtained from this chromatography was subjected to solvolysis as described (12). The solvolysed and the "free" fraction were chromatographed on TLC in system chloroform-acetone 9rl. The monohydroxy-pregnanes were eluted as a group as they migrated with Rf-values of 0.52-0.57 in this system. The eluted fractions were further chromatographed in system n-hexane-ethyfaoetate 3:l with three developments.In this step J&-hydroxy-5D-pregnan-20-one (%-50-P)was separated from the other epimers.After derivative formation (Monochloroacetate)the fractions were purified by another chromatography on TLC in system benzene-ethylacetate lO:l.The solvent systems and Rf-values are listed in table 1. Quantitative determinationrAfter removal of an aliquot to determine procedural losses by counting the remaining radioactivity the fractions were subjected to GLC and electron capture detection. Testosterone-monochloroacetate was used as internal standard and the mass of the individual steroids was calculated according to the following formulas P (ng) = R x SF x PF x IS x MP P

= Pregnanolone

R

= Recovery Peak area = Peak area

SF

Peak Peak

area area

of internal of standard

of oreunanolone in sample of internal standard in sample

PF

=

IS

= ng of internal

MF

=

Molecular Molecular

standard pregnanolone

standard

weight weight

added

to sample

of nreananolone of pregnanolone-monochloroacetate

20a-hydroxy-4-pregnen-3-one (2QcyJOH-P) was determined by GLC as described (8), Progesterone in tissue extracts was determined by radioimmunoassay (13) using an antiserum against lli3-OH-progesterone-hemisuccinate serum albumin. The extracts were purified before the binding assay by chromatography on Sephadex LH-20.All determinations were performedin duplicata

S

68

TBEOlCDI

Solvent I

Compound

systems

II+

III

IV

Progesterone

.80

.43

2orr-OH-P

.53

.27

POD-OH-P

.52

.29

3tY-5ar-P

.55

.49

.69

l34

3a-_5a-P

.54

.42

.70

433

30!-5a-P

.57 l57

935

3a-go-P

l54

.68 .66

l39 .26

3a-A5-P +

.56

.47

.65

.36

200

5&-p**

.61

.46

SQI-P-dione 5D-P-dione

.86 .86

.70 l66

Testosterone

.46

023

.30

.68

Rf-values, Table 1: Thin layer- chromatography, * = 3%hydroxy-5-pregnen-ZO-onej + e three developmentsj ** = 20Q-hydroxy-5Q-pregnan-3-onej I = Chloroform-Acetone 3rtj III = Benzene-Ethyl9rt; IL I n-Hexane-Ethylacetate 8:2. acetate 10:lj IV = n-Hexane-Diethylether

RJEWLTS 1.

Recovery From

taining labelLed cessed.

and

accuracy;

a pool

of Krebs-Ringer

3&%-P,

each

of 5a-P-3a-so4

and

labelled

compounds.

labelled

compound

mination

by GLC

recovery,

and

5a-P-3%SO4

compounds, 5 ml

bicarbonate

12 samples contained 3600

yielded

representing

ng 3&5ar-P,

cpm reap.

40.1 were

the corresponding

of 5 ml were

780

2900

f. 6.5% of the

recovered. 746 f 96% 3

buffer

The

taken the

contritium

and pro-

same

amount

cpm of radioactive "free"

radioactive

quantitative

105 ng,corrected 14% of added

by

3&-!$a-P.

detertracer

The

recovery 11s.

56,8$&

94% 2 8% of the ments lues for

with

of radioactive

added

biological

of recovered the

722.9

By GLC

"free"

f

labelled

56 ng were

5iacP-30-SOb

measured

pregnanolone-sulfate. material

radioactive

compounds

and

(Exp.

is

In the experi-

1-21,

material

was

which

table

were

31% f. 6% for

4) the va-

51% +

10.5%

the "sulfates".

2. Precision: The mated

precision

from

3&w-P

the duplicate

and

5&-P-32-SO4

variation

was

pound

7.896 for

and

of quantitative

1496 for

determination

experiments

(n P 12) with

to EBB-buffer.

The

the determination

the determination

was

esti-

added

coefficient

of the

of the

free

of

com-

sulfate.

7. Sensivitv: As

5 ng of the monochloroacetyl

quantitated of the method determinations

sufficiently is about are

by GLC 50 ng

derivative

the practical

steroid

per

can be sensitivity

sample

if several

to be performed.

Fia.1: Gas-liquid chromatography of monochloroacetate derivatives of pregnanolones isolated from myometrium (Exp.1). Column: 3$ QF-1, 6 ft. On the absaissa time in minutes. For details of GLC see methods. The shaded areas depict the amount of authentic substances injected together with the biological sample. 1 = P-hydroxy-SQ-pregnan-20-one; 3 I 3S-hydroxy-5-pregnen-20-one; 4 = 3B-hydroxy-%-pregnan-20(Internal standard). one; 5 = testosterone-ClAc

S

70

lclpEOSDI

4. Specificity The ral

specificity

of

chromatographic

compounds

with

monstrated measured

the method

steps;

two of

the epimeric

compounds

with

authentic

peak

sample

to GLC

was

(Figl).The

subjected separation

in table

2 where

spect

to testosterone

Table

2: Relative

relative

time

of

when

time

1.0

1.0

1.0

1.0

200r-OH-P

1.87

1.54

1.53

-

2Of3-OH-P

1.71

1.36

1.40

-

zau-W-P

1.25

-

-

-

was

de-

of the

demonstra-

the biological

with

the

standard

pregnanolones retention standard

is demon-

times are

(Rt) during

testosterone

Testosteron,

was

seve-

tracer

identity

material

together

as internal

retention

(Retention

The

increase

of epimeric

by

of added

pregnanolones

by radiogaschromatography.

ted by a symmetrical

strated

is determined

the identity

with

re-

compiled.

GLC

= 1)

1.0

1.0

1.0

1.84

1.70

1.56

-

-

1.59

1.42

-

-

-

-

-

957

.55

.5?

1.22

1.15

1.0

1.0

%-W-P

.61

957

.59

029

.58

.52

3n-5o-P

.59

.5?

.59

.30

.59

.55

.5?

.54

.5?

3lz-513-P

-68

.58

.61

-66

.5?

-57

.85

.68

.?4

.81

.?2

.58 l?2

.61

3a-5g-P

.52 .34

.go

.?l

3g-AK43

.84

‘68

.?l

.48

.?8

.65

.66

.80

l66

71

This ment

1 by measuring

rivativea ment

criterion

one

total

uteru8

columns (960

purified

of the indicated

retention strated

time under

completed

GLC.

g wet weight)

as the authentic

different In this

was

are

with

standarda

conditions

de-

experi-

extracted

same

could

and

In

compiled,

the

The

relative

be demon-

of GLC.

n&g

Compound

Table

in experi-

chromatography.

experiment

compounde

six different

using

during

by additional

2 the rerrulte of this

presence

and

the 8p111efractions

and different

the extracts table

W~IB checked

3R-5u-P

+

+

+

+

+

4

18.7

h-&-P-S04

+

+

+

+

+

+

35.6

3&5&P

_

-

-

-

_

-

-

3S_5S_P_SO4

_

-

-

-

-

_

.

32..ggl-P

+

+

+

+

+

+

38.7

3a-5cr-P-SO4

+

+

+

+

+

+

9.4

3a-5a_p

_

_

_

_

*

-

-

3nL5%P-SO4

*

+

+

+

+

+

15.2

3l3-A5-P

+

+

+

+

+

+

25.8

313-A5-P-SO4

+

+

+

+

+

+

a.9

3:

Exo.1: Isolation of Pregnanolones from myometrium (970 g + indicate8 demonstration tiabue, 40. week of pregnancy). of compound with identical relative retention time ae the reference compound (these values are shown in table 2) a symmetrical peak increase after injection of authentic compound8 together with analysis sample.

S

72

Concentration

of metabolites

In experiment could

from

(k-%-P)

(3&5c+P), fate,

and

and

addition

3)

the

three

tissue.

tissue:

epimeric

as

the

free

compound

3a-sulfoxy-50-pregnan-20-one there

its

sulfate.

not

be

was

The

found.

compounds

a-hydroxy-W-pregnan-

3B-hydroxy-w-pregnan-20-one

present

both

in uterine

1 (table

be isolated

20-one

TREOXDI

and

(50-P-3&-S04).

3D-hydroxy-5-pregnan-20-one

epimer

30-5o-P

with

was

as sul-

metabolite

and could

3Lb5l3

the configuration

the main

In

(d5-P)

in this

uterus. In experiments ted. the

small

samples

each

same

uterus.

In table

oompiled. 35-k-P

The and

centration only was

2-21

Two

from not

In a water

blank

detected

titative (Exp.

of are

compounds

samples

were

the

processed

by

which

in

which

In the other

determination

extrac-

parts

results

or below

peaks

were

different

4 the quantitative

sulfoconjugate

detected

samples

from

to 296 rig/g tissue.

6 samples.

were

tissue

taken

predominant

its up

were

these

were

present

3a-5a-P

was

specimens

sensitivity

this of

the described

could

interfere

of the different

in con-

isolated steroid

the method. method

with

no

the quan-

pregnanolones

22). Progesterone

determined

also.

concentrations the reported The

could between

The

range

results

one

tissue

included were

the nonpregnant

amount of

be detected,

samples

in table

found

in the

uterus

of progesterone

the saturated There

the concentration

metabolites

are

steroids

these

were

4. The

to be within

(5).

from

a small nor

~OCY-OH-P in

of these

tissue

contained 2OeOH-P

and

was

no

but

2 and

3)

neither

progesterone statistical

of progesterone

tissue.

(Exp.

metabolites

correlation and

those

of

the

poetov. Ph. postov.Ph.

IO. 10.

Il.

2 3

4 5

6 7

18. 18.

18. 18.

18. 18.

24. 24.

41. 41.

12

13

14 15

‘16 17

18 19

20 21

22

Water

12. 12.

11

IO

5ml

5::

;::

;::

;:::

5.4 5.2 I

;::

-

28.1 17.5

23.8 36.0

114.4 75.9

121.1 116.9

106.7 81.2

%*43.

135.6 90:2

;::

11.

11.

x

zx

z

40.4 18.9

5.2 5.3

55.8 11.5

11.7

6.9 12.2

20.7 23.9

Z:;

37.2 20.4

7.8 11.7

2:: 245

I

52.7 40.6 50.6 81.8

10.0 10.5

120.9 33.1

10.0

35.2 10.0

10.0 110.8

72.5 30.3

9.4

22.6

18.6 12.4

18.7

128.5 110.6

I

5ty-P-3f3-so4

Wet weight)

10.0

32.4 30.4

32.3 38.0

21.2 61.4

23.4 52.9

35.0 41.9

249.1 296.4

10.0

22.5

24.6 19.2

38.7

(na;/g

3u-5a-P

muSCle

3i3-5qs-P

uterine

20 Cy-OH-P

in

I de teranined ;:;

not

4.9 5.2

970.0

Prog.

and metabolites

11.

blank

40.

1

Tissue (g)

4% Progesterone L

Pxp. Week of Pregnancy lo.

Pablo

24.0 13.3

12,9

IO

35.6

5~P-srrso4

DISCUSSION Assuming organ

that metabolism

is related

to hormone

of a hormone action

gained

by determining

the concentration

parent

steroid

tissue

From

in the

the 20 isomeric

from

progesterone

four

which

special

are

reduced

shown

to occur

ring

A was

found

target

By

tissues

these

be formed

depending

The

quantitative

ses

fundamentally

3 and

any

which

tissue may

steps

on

four

the enzyme

determination the

separation

the

molecule

5 only

the

are

which

saturation

be regarded

of has of

as so

(14).

epimeric

compounds

patternmin

of

of

be

can originate

steroid

of progesterone

metabolic

only

to 20q-reduction

in almost

target

could

the metabolites.

which

at positions

in organs

not of

of the

In contrast

interest.

also

compounds

by reduction

been

called

but

in its

information

these

may

the cells.

metabolites

of epimers

and

suppo-

sensitive

detection. Both and

criteria

electron

Adlercreutz the

tion

by GLC.

of TMSX

these

and

and

liquid

These

to about

chromatography

Chamberlain

& Thomas

SjZSvall (17) have

the quantitative

derivatives

methods

by gas

detection. (16)

et al.

separation

nanolones

are met

capture

authors

100 ng

reported

determination

however

which

limits steroid

used the

(15), on

of preg-

flame

ionisa-

sensitivity

in biological

of mate-

rial. Concerning nes

and

tion Molen

electron

separation

fs available. & Groen

progesterone

nanolones. these

(8) for

As

it appears

detection by GLC

the quantitative

electron

by

that

capture

the relative

as compared the

of pregnanololittle

to the method

smaller

of van

derivative detection

retention

to TMSI

informa-

determination

the monochloroacetyl

and

shown

derivatives

columns

In analogy

we used

gaschromatography

capture

of derivatives

ethers

derivatizing

of for

of preg-

times on

der

of

the same group

of

the monochloroacetate epimers sated and

during

however

longer

tection

les

to buffer

of uterine

GLC-methods This thod

by

are within

the

which

conditions

been

with

samples

of step

biological range

specificity

samp-

of other

of the me-

could

with

interfere

results

elithe

of experiment

of the method

could

with

3 derivatives

1

as the

be determined

of the method

demonstrated of human

it can be

metabolites

in the

under

on 3 different

that

were

In similar

the tissue. was

The

myometrium

found

Though phase

The

in uterine

isolated

range

concentration

comparable

determination.

and

From

these

during

preg-

3a-hydroxy-5aand in the was

iso-

as progesterone

in

of 3a-hydroxy-5a-pregnan-

to 20a-hydroxy-k-pregnen-3-one. if present

by TLC epimer

the samples

before

with

tissue

from human

of cycle

and

a8 "free** steroids

quantitative

eliminated

2-21).

3I3-hydroxy-5a-pregnan-20-one

3a-hydroxy-5D-pregnan-20-one as it was

experiment

(Exp.

in human

found

fraction.

mate-

!ja-reduced progesterone

30-hydroxy-Sa-pregnan-20-one

"sulfaten

to biological

same

myometrium

stated,

are present

pregnan-20-one

tory

amount

the

phases.

has

been

of

steps

The

pregnanolones

rial

not

of de-

chromatographic

specificity

applicability

20-one

with

similar

the

the different

The

lated

for

determination.

six differnt stationary

also

compounds

epimeric

nancy.

of known

as demonstrated

true

support

results

sensitivity

(QF-1)

(17). holds

quantitative

three

phase

and precision

by addition

and

other

further

the

lr5.

muscle

provided

minating

hand

of

can be compen-

stationary

reproducibility

accuracy,

effect

a selective

On the other

columns.

as determined

raids

the separation This

chromatography. by using

ie increased

The method

diminishes

was

not

the gaschromatographic

the configuration

and

determined

to our knowledge

3ib513 has

was

never

tissue. from

contained

a uterus none

of

of the postovulathe saturated

meta-

S

76 bolites

a correlation

progesterone

or

lones

tissue

in

the

The rone could

be

between

could

from

trapped

during

side

in

tively rine

higher muscle

these

of

blood

as

and

their be

metabolites in

of

in (17)

Sjiivall

contribution

progeste-

this

tissue

cannot

on

determined

by

pregnano-

of

blood

concentrations

reported

cannot

and

originate

as

endogenous

established.

circulation The

maternal and

be

myometrium

definitively.

experiments

not

whether

answered and

concentrations

20q-hydroxy-4-pregnen-3-one

question

isolated

TmEIEOXDI

to

the

the

or

be

fetal

preliminary are

compara-

amount

in

ute-

excluded.

ACKNOWLEDGEMENTS P.

I thank Dr. Munich University, The skilful graphy. gelt is gratefully

Unterburger, I. Dept. Int. Med. of who performed the radiogaschromatotechnical asistance of Miss P. Fiinfacknowledged.

The study was supported Forschungsgemeinschaft,

by Mi

the Deutsche 109/4

REFERENCES 1.

Wiest,

2.

Wichmann,

3.

Rossier, 36,

K.; G.;

169

Sweat,

5.

Runnebaum,

M.L.

7.

Bryson,

B., 150

Horning,

(Kbh) C.G.;

Suppl. J.

116

(1967)

REPROD.FERT.

M.J.;

AM.J.OBSTET'.GYNEC.

106,

van

E.C., GLICK

in: IX,

INTERSCIENCE

Horning, E.M., 283

(ed.),

E.C.,

Jaakonmaki, (1967)

Zander,

J.;

ACTA

ENDOCR.

(Kbh)

(1971)

D.

5,

ENDOCR.

(1963)

(1970)

SUPPl., 6.

ACTA

Pierrepoint,

310

(1974)

4.

193

73,

ENDOCRINOLOGY

W.G.;

den

Heuvel,

METHODS

PUBLISHER, Horning, P.J.,

OF

E.J.A.,

Greeck,

BIOCHEMICAL

New-York-London

M.G., Brooks,

Ikegawa, C.J.W.;

B.G.

ANALYSIS 1963

N.,

Chambaz

GASCHROM.

8.

van

der Molen, 6,

STEROIDS 9.

Kirechner, 346

10.

H.J.,

195

D., van

der Maas,

9-H-i

(1965)

M.A.,

Taylor,

J.P.;

ANALYT.

BIOCHEM.

30,

(1969)

Mickan, 477

H.,

Dixon,

R.,

Hochberg,R.B.i

STEROIDS

13,

(1969)

11.

Vihko,

R.5

12.

Jl~e,

O., Vihko,

CLIN.

Hoffmann,

14.

Morgan,

302

3781

ACTA

CHIM.

13.

4,

Grow,

ENDOCR.

ACTA

R.,

(Kbh)

23, 405

B., Kyrein,

Suppl.

SjLivall, J.,

(1966)

109

SjilVall, K.;

(1969)

H.J.,

Ender,

M.L.;

J.D.;

J. BIOL.

HORM.RES.

(1973)

M.D.,

Wilson,

CXEM.

245,

(1970)

15.

Chamberlain,

16.

Adlercreutz,

J., Thomas,

G.H.8

ANALYT.

BIOCHEM.

8,

104 (1964)

J. STEROIDS 17.

Sjiivall, K.;

H.,

Luukainen,

T., Tayler,

E.;

1, 117 (1966) ANN.

CLIN.

RES.

2, 393

(1970)

EUROP.